WAVE Life Sciences Revenue and Competitors

Claim your profile

Boston, MA USA



Total Funding



Estimated Revenue & Valuation

  • WAVE Life Sciences's estimated annual revenue is currently $74.9M per year.(i)
  • WAVE Life Sciences received $93.4M in venture funding in April 2017.
  • WAVE Life Sciences's estimated revenue per employee is $264,541
  • WAVE Life Sciences's total funding is $174M.

Employee Data

  • WAVE Life Sciences has 283 Employees.(i)
  • WAVE Life Sciences grew their employee count by 10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Wave Life Sciences Ltd. (NASDAQ: WVE) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. Given the unique versatility of its chemistry platform, Wave's pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





WAVE Life Sciences News

2022-04-06 - Should You Add Wave Life Sciences Ltd (WVE) Stock to Your Portfolio Tuesday?

Wave Life Sciences Ltd's score of 57 means that it ranks higher than 57% of stocks in the sector. In addition, its overall score of 9 ranks it...

2022-04-06 - Wave Life Sciences Ltd. (NASDAQ:WVE) Expected to Announce ...

Wave Life Sciences posted earnings of ($0.86) per share in the same quarter last year, which would suggest a positive year-over-year growth rate...

2022-03-30 - Wave Life Sciences Announces Positive Update to Ongoing Phase ...

Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people...

2019-09-07 - Wave Life Sciences (NASDAQ:WVE) Cut to “Sell” at BidaskClub

Wave Life Sciences (NASDAQ:WVE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note ...

2019-09-07 - Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019

06, 2019 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (WVE), a clinical-stage genetic medicines company committed to delivering ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

WAVE Life Sciences Funding

DateAmountRoundLead InvestorsReference
2015-02-03$18.0MARA Capital Management LLCArticle
2015-08-19$66.0MBForesite CapitalArticle